2014 is poised to be a big year for marijuana legitimacy. Earlier this year, Washington and Colorado legalized the use of recreational marijuana, and perhaps more importantly, the Department of Justice clarified that it will not pursue legal action against institutions that choose to involve themselves in the booming weed economy so long as they follow a list of guidelines. But while lifting prohibition for recreational use may still be a ways off for most states, many are now taking a hard look at their regulatory stance on medicinal usage, and the result have been surprising.
On June 16, Florida passed a bill that allows for the usage of a low potency strain of medicinal marijuana that has been praised for its success treatment of epilepsy, Lou Gehrig’s disease and certain cancers. Known as CBD or “Charlotte’s Web,” the strain has been processed to remove much of the high-inducing tetrahydrocannabinol typically found in marijuana, and is often used to treat children affected by those ailments.